MARATTO

article · Naunyn-Schmiedeberg s Archives of Pharmacology

Mechanistic insights into the hepatoprotective role of rabeprazole against cyclophosphamide-induced hepatotoxicity via AMPK/SIRT1 activation and suppression of TLR4/NF-κB and MAPK pathways

20253 citationsSuez University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Chemotherapy-induced organ toxicity mitigation
  • Drug-Induced Hepatotoxicity and Protection
  • Hematopoietic Stem Cell Transplantation

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s00210-025-04577-y

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.